- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Shruti Agnihotri Highlights the Importance of Value-Based Neurologic Care for Post–COVID-19 Patients
Shruti Agnihotri, MD, associate professor at the University of Alabama Birmingham, discusses how value-based care can help patients who experience neurologic chronic disease states after COVID-19, in addition to patients with conditions like stroke and dementia.
Value-based care is important for patients who experience neurologic issues after COVID-19, as well as patients with stroke and dementia, says Shruti Agnihotri, MD, associate professor at the University of Alabama Birmingham.
Transcript
What role does value-based care play in neurological conditions?
Value-based care is very important in neurologic conditions—many different neurologic conditions, of course, in things like dementia, strokes—but I think it's also important in our post–COVID-19 patient population. At the heart of what we do so far for our post–COVID-19 patients is managing high blood pressure, diabetes; the chronic conditions, chronic states, which affect how the brain will function for these patients. I think, yes, there is a large role that value-based care or managed care can play in these patient care situations.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More
